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Introduction 
Endoscopic vein harvesting (EVH) became the 
standard technique for many centers because of 
its significant advantages over open vein 
harvesting (OVH) in minimizing wound infection, 
achieving early ambulation, better cosmesis, and 
lower hospital stay. Thrombus formation inside 
the vein lumen is one of the main concerns of this 
technology [1]. Some studies recommended giving 
a prophylactic dose of heparin to prevent this 
complication, especially in the CO2 closed 
systems. In contrast, other research did not 
recommend heparin in open CO2 systems like 
(VirtuoSaph plus ® Endoscopic Vessel Harvesting 
System, Terumo), taking advantage of avoiding 
the unfavorable bleeding tendency during 
internal mammary artery harvesting [2].  
In Press
Abstract 
Background: Endoscopic vein harvesting (EVH) became a standard technique with 
several advantages over open vein harvesting (OVH). Thrombus formation inside the 
vein lumen is one of the main concerns after EVH. It is not known whether heparin 
use before EVH could prevent this complication. The study aimed to assess the safety 
of not giving intravenous heparin before starting the open system EVH procedure 
using the PeriVu™ Disposable Angioscopy (LeMaitre® VASCULAR- France) as a 
modality to assess the intraluminal vein clots. 
Methods: This research is a randomized study that compared two groups of patients 
undergoing CABG. One group had 2500 IU heparin before EVH using (Virtusaph plus, 
Terumo) (n=50) and the other group had EVH without giving heparin (n=50). 
Intraluminal clots in the vein segments were evaluated using PeriVu Disposable 
Angioscopy (LeMaitre-VASCULAR). 
 Results: Preoperative data were comparable between groups with no statistically 
significant difference. The mean duration of the procedure in the heparin group 
versus the non-heparin group was 30.6±5.8 and 28.7±5.9, respectively (P= 0.11). 
Intraluminal clots were detected in two segments out of 103 segments (1.94%) in 
the No heparin group, while none was detected in the heparin group (P= 0.24). 
 Conclusion: There was no difference between heparin versus no heparin during 
endoscopic vein harvest regarding intraluminal thrombus formation. Further studies 
are recommended to confirm our findings. 
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Currently, there is no consensus supporting 
giving heparin before the procedure. This study 
aimed to assess the safety of not giving 
intravenous heparin before starting the open 
system EVH procedure using the PeriVu™ 
Disposable Angioscopy (LeMaitre® VASCULAR- 
France) as a modality to assess the intraluminal 
vein clots. 
Patients and methods: 
Study Design: 
This research is a randomized study carried out 
in Al-Dabbous Cardiac Center, Kuwait. Two 
strategies of endoscopic vein harvesting using 
(Virtusaph plus, Terumo) were compared. We 
gave heparin 2500 IU at the onset of the 
procedure in one group, and the second group was 
without heparin. PeriVu™ Disposable Angioscopy 
(Figure 1) is a tool that features a unique 10.000 
pixel, fused optical fiber bundle that provides a 
sharp, direct visualization of the vein lumen to 
evaluate vein quality and the absence of clot in 
both groups to ensure the safety of using the vein 
conduit in coronary bypass grafting. The operating 
two surgeons reported unfavorable bleeding 
difficulty during internal thoracic artery harvesting 
as difficult or not without knowing to which group 
the patient belonged.  
Figure 1: Le Maitre Angioscope 
Study population 
One hundred consecutive ischemic heart 
disease patients undergoing coronary bypass 
grafting (CABG) were included in the study and 
divided into two groups (Heparin group, n=50 and 
non-Heparin group, n=50).  
Inclusion criteria 
We included all IHD patients undergoing CABG 
with two or more grafts and at least a single 
venous graft. 
Exclusion criteria 
Exclusion criteria included any patients on 
preoperative heparin for any indication or 
duration and any patient with a preoperative plan 
for total arterial vascularization. 
Study conduct 
The study started in April 2018 until January 
2020.  One hundred consecutive patients were 
included in the study. Two experienced surgeons 
did all endoscopic procedures with an experience 
of more than 300 endoscopic procedures for each. 
Another member of the surgical team was 
assigned to randomize the patients and to 
document all demographic data and the depth of 
the great saphenous vein reported by the Doppler 
study preoperatively, recording the duration of 
the harvesting procedure, the number of 
segments, and the presence or absence of any 
intraluminal clot detected by the angioscopy (Peri 
Vu, Le Maitre, France). 
The technique of vein harvesting 
A standard technique of EVH was followed. 
Preoperative routine ultrasound was done to 
assess the veins quality, size, and depth (the 
distance from the skin's surface to the upper 
surface of a vein) anteriorly. The patient was 
positioned in a frog-like position. An incision about 
2 cm in the upper leg or lower thigh just above the 
medial aspect of the knee was done, with careful 
dissection and identification of the great 
saphenous vein. This was followed by insertion of 
the traumatic conical tip of the dissector and starts 
dissection for the whole length of the vein 
posteriorly, anteriorly, and laterally. Then 
insertion of V-keeper gently to protect the vein 
during harvesting and using V-cutter (bipolar 
electrosurgical energy) delivers high-frequency 
electrical current and voltage causing desiccation 
and vaporization of the target tissue. The device 
encapsulates the main conduit and 
simultaneously seals and cuts the branches near 
the tunnel wall. 
After vein harvesting, injection of heparinized 
saline solution in the vein, covering the angioscopy 
tip with a small rubber cap to avoid injury to the 
vein's intima during its advancement inside the 
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lumen in a retrograde manner. It was taken into 
consideration to discard any segment with an 
intraluminal clot, tear, or any damage to the 
intima. 
Statistical analysis 
All data were collected preoperatively in a 
departmental database (patient analysis and 
tracking system, Dendrite clinical, UK). Categorical 
data were presented as percentages and 
frequency. Mean and standard deviations were 
provided for continuous variables.  
Categorical data were compared using the Chi-
square test or Fisher exact test when appropriate 
and continuous data were compared using the 
Student t-test. Statistical analysis was performed 
using SPSS version 27.0 (SPSS, Armonk, NY, USA). 
A P-value of less than 0.05 was considered 
statistically significant. 
Figure 2: Clot inside the vein lumen as seen by the 
angioscopy 
Results: 
Demographic data, including age, sex, body 
mass index (BMI), diabetes (DM), hypertension, 
dyslipidemia, smoking, renal insufficiency, and 
the depth of the veins, are summarized in Table 
1. There were no statistically significant
differences between both groups. The incidence 
of peripheral vascular disease (PVD) was 4% in 
both groups.  Veins adherent to the skin were 
observed by preoperative ultrasound in 5 
patients (10%) in the heparin group. In 
comparison, it was observed in 6 patients in the 
No heparin group (12%) (P=0.75). 
The procedure duration in the heparin group 
ranged from 20 to 40 min with a mean of 30.6± 
5.8. In comparison, it ranged from 18 to 45 min 
with a mean of 28.7±5.9 in the no heparin group 
(P= 0.11). 
The intraluminal clot was detected in two 
segments out of 103 segments in the No heparin 
group (1.94%) (Figure 2). No intraluminal clot was 
detected in any segment examined in the heparin 
(P= 0.24). 
Internal Thoracic Artery (ITA) harvesting was 
reported difficult in 22% (n=11) and 20% (n=10) of 
patients in the heparin versus the no heparin 
groups, respectively (P= 0.81). 
Discussion 
Coronary artery bypass grafting (CABG) is still 
the most common cardiac surgery procedure 
representing annual volumes of approximately 
200,000 isolated cases [3] in the US and an 
average incidence rate of 62 per 100,000 
inhabitants in western European countries [4,5]. 
Despite the increasing use of arterial conduits, the 
great saphenous vein is still the most commonly 
used graft because of its ready availability and 
ease of use [6,7]. The patency rate of these SVGs 
was attributed to many factors related to the 
patient as hypercholesterolemia, diabetes 
mellitus control, hypercoagulable state, calcific or 
atherosclerotic aorta, bad target with poor distal 
runoff and discharge therapies. Other factors 
related to anastomosis or SVG harvesting 
techniques, either open or endoscopic, could 
affect the patency [8,9].  
Many studies showed no significant difference 
between open and endoscopic techniques in 
graft patency [10]. The International Society for 
Minimally Invasive Cardiothoracic Surgery in 2017 
published a consensus statement giving a Level 1B 
recommendation for endoscopic conduit 
harvesting [11]. Still, other studies accused clot 
formation and intimal tears inside the EVH 
segments of shorter patency, especially for acute 
graft failure [12].  
Some studies comparing the open versus close 




Table 1: Comparison of preoperative and operative data between groups 
Heparin Group (n= 50) No Heparin Group (n= 50) P-value 
Male 34 (68%) 31 (62%) 0.53 
Age (years) 58.86± 10.35 59.04± 7.59 0.92 
Body mass index (Kg/m2) 27.25± 5.91 27.68± 5.35 0.71 
Diabetes mellitus 28 (56%) 25 (50%) 0.55 
Smokers 21 (42%) 19 (38%) 0.68 
Peripheral vascular disease 2 (4%) 2 (4%) >0.99 
Hypertension 30 (60%) 29 (58%) 0.84 
Renal failure  2 (4%) 2 (4%) >0.99 
Dyslipidemia  13 (26%) 16 (32%) 0.47 
Veins adherent to skin  5 (10%) 6 (12%) 0.75 
Harvest duration (min) 30.6± 5.87 28.7± 5.92 0.11 
Number of segments 2.12± 0.59 2.06± 0.68 0.64 
Intraluminal Clots 0 2 (1.94%) 0.24 
Difficult internal thoracic artery harvest 11 (22%) 10 (20%) 0.81 
showed that clot burden is less with the open CO2 
insufflation technique even in the absence of 
heparinization before initiation of the procedure 
and the recommendation of systemic 
administration of heparin before occluding flow 
using a sealed CO2 system led to dramatic 
reductions in this retained clot. Pre-heparinization 
before EVH was believed to increase the technical 
difficulty of internal thoracic artery harvest, owing 
to increased oozing in the surgical field and may 
cause an increased incidence of bleeding and 
hematoma in the tunnel of EVH [2]. Although the 
difficulty was more in the heparin group, it did not 
reach a statistically significant difference. Till now, 
there is no recommendation for systemic 
heparinization before the open CO2 insufflation 
EVH technique. The use of open CO2 insufflation 
to maintain flow within the saphenous vein 
prevents stagnation of blood within the 
saphenous vein with subsequent less clot 
formation.  
To our knowledge, this is the first study to 
compare clot formation with open CO2 
insufflation endoscopic system (VirtuoSaph plus ® 
Endoscopic Vessel Harvesting System, Terumo) if 
preoperative heparin was given using the PeriVu™ 
Disposable Angioscopy (LeMaitre® VASCULAR). 
Both groups showed no statistically significant 
differences in the risk factors for venous clot 
formation. There were only two cases with an 
intraluminal clot in the non-heparin group 
patients compared to zero clots in the heparin 
group without a statistically significant difference. 
Those clots were found in the distal leg segments 
where the SVG was superficial. The heparin group 
also had six superficial veins without any clot 
found. We assume that even with the open CO2 
insufflation system, blood stagnation in the 
superficial saphenous vein is unavoidable and may 
risk clot formation. This stagnation causing clot 
formation was evident from our experience using 
angioscopy before this study when we were using 
a technique to insert a drain into the endoscopic 
tunnel by tying a Ticron suture to the proximal end 
of the vein before cutting it then we were dragging 
the suture together with the vein through the 
distal end of the tunnel leaving the proximal end 
of the stitch to tie it to the drain to pass it back to 
the tunnel. With this technique, we found three 
consecutive segments with intraluminal clots near 
the proximal segments. We stopped this 
technique since that time. All the segments in the 
two groups were with no gross intimal tears, 
healthy intima. 
Conclusion 
There was no difference between heparin 
versus no heparin during endoscopic vein harvest 
regarding intraluminal thrombus formation. 
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